| Nov 12 |
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2024 and Updates Guidance
|
| Nov 12 |
Earnings Scheduled For November 12, 2024
|
| Nov 7 |
Artivion (AORT) Tops Q3 Earnings and Revenue Estimates
|
| Nov 5 |
SI-BONE Receives Transitional Pass-Through Payment Status for iFuse Bedrock Granite™
|
| Oct 30 |
Strength Seen in Si-Bone (SIBN): Can Its 6.9% Jump Turn into More Strength?
|
| Oct 22 |
SI-BONE To Report Third Quarter 2024 Financial Results on November 12, 2024
|
| Oct 14 |
SIBN Stock Up After First-In-Patient Use of FDA Breakthrough Device
|
| Oct 14 |
First patients are treated with Si-Bone’s pelvic fracture fixation device
|
| Oct 10 |
SI-BONE, Inc. Announces First-In-Patient Procedures with FDA Breakthrough Device for Pelvic Fracture Fixation
|
| Aug 26 |
Wall Street Analysts Think Si-Bone (SIBN) Could Surge 40.3%: Read This Before Placing a Bet
|
